Jesse Mondry

Jesse has an extensive domestic and international litigation background. He has represented clients in a wide range of industries, including construction, retail, manufacturing, real estate, and banking. His analytical mind, excellent writing skills, and steady presence allow him to find unique solutions to complicated domestic and international dispute resolution issues.

In every dispute, it is Jesse’s goal to find the best and most cost-effective solution for his clients. He has a natural ability to convey his clients’ interests to judges, juries, mediators and arbitrators, but he also puts in the time to ensure the best attainable result in any given matter.

Jesse graduated magna cum laude from the University of Minnesota Law School and held a highly competitive federal court clerkship with the Honorable Myron H. Bright of the Eighth Circuit Court of Appeals. Before that, he also served as a law clerk to Honorable Thomas J. Kalitowski in the Minnesota Court of Appeals. Prior to joining Harris Bricken, he spent seven years practicing complex commercial litigation at a large firm in Minneapolis, Minnesota.

In his spare time, Jesse likes to sail and spend time with his family.

Jesse Mondry
by

We have been tracking hemp-related litigation for some time. We’ve written about disputes between hemp growers and purchasers, seizures of hemp by law enforcement, consumer class action lawsuits, bankruptcy and other business disputes. Here are just a few of those articles: Oregon Hemp Litigation: New Cases Demonstrate the Continued Importance of Due Diligence Oregon Hemp-CBD […]

Jesse Mondry
by

  We regularly write about arbitration as an alternative to litigation on this blog and on our sister blog, the China Law Blog. Topics have included the pros and cons of arbitration in the cannabis industry, international arbitration issues, and U.S. Supreme Court cases: Cannabis Litigation 101: Arbitration Cannabis Arbitration: The Good, The Bad, and […]

Jesse Mondry
by

Earlier this year we wrote about the movement to decriminalize psilocybin – noting its success in Denver, Oakland, and Santa Cruz – and that nearly 100 other cities are looking at decriminalizing psychedelics. (The Psilocybin Movement is Like the Cannabis Movement (Except When It’s Not)). That article posited that psilocybin would move along two tracks […]

Jesse Mondry
by

Colorado-based United Cannabis Corporation (“UCANN”) filed for Chapter 11 bankruptcy protection on April 22. Regular readers may recall that UCANN is the plaintiff in the first ever cannabis patent protection case which generally concerned liquid cannabinol formulations of a purified CBD and/or THC greater than 95%. That litigation is now stayed (paused) as a result […]

Jesse Mondry
by

A couple of months ago we reported on a decision in the Southern District of Florida in which the court stayed a putative class action lawsuit against a seller of cannabidiol (CBD) products until the Food and Drug Administration (FDA) completes rulemaking regarding the marketing, including labeling, of hemp-derived ingestible products. The case is Snyder […]

Jesse Mondry
by

A few weeks ago, Hilary Bricken wrote about the proliferation of ketamine clinics in the United States and the logistics and legalities of operating a ketamine infusion clinic. As Hilary explained, the only FDA approved use of ketamine is for the induction and maintenance of anesthesia, though it also used for off-label infusions in the […]

Jesse Mondry
by

Last week, Vince Sliwoski wrote a post titled “Cannabis and Coronavirus: What Your Business Should Do Right Now” offering some high-level thoughts on how to mitigate the impact of COVID-19 on cannabis businesses. One of the topics included reviewing contracts, regarding which Vince said: Pull these out and dust them off, whether it’s a lease, loan […]

Jesse Mondry
by

The hemp-derived CBD market is a tough one right now. From uncertainty in when and how the FDA may begin regulating products, to the downturn in the stock markets as result of the coronavirus affecting the hemp industry, the problematic interim rules concerning hemp production and increasing state regulation, CBD companies face a plethora of […]

Jesse Mondry
by

Not long ago Hemp Industry Daily reported on a decision by U.S. District Judge Ursula Ungaro in the Southern District of Florida in which the Court stayed a putative class action lawsuit against a seller of CBD products until the FDA completes rulemaking regarding the marketing, including labelling, of hemp-derived ingestible products. The case is […]

Jesse Mondry
by

Although I am a litigator who loves to be in court, I often counsel clients on how to avoid litigation – even though it may mean less work for me in the future!  Front and center in these discussions are: 1) the importance of due diligence prior to entering a new business relationship and 2) […]

Search

 
 

About this Blog

The Canna Law Blog™ is a forum for discussion about the practical aspects of cannabis law and how it impacts those involved in this growing industry. We will provide insight into how canna businesspeople can use the law to their advantage…

Read More

 
 

Stay Connected

   

 

SUBSCRIBE BY EMAIL

 
 

Topics

Archives

 
 
 
 

Disclaimer

Please be mindful that possessing, using, distributing and selling marijuana are all federal crimes and that this blog is not intended to give you any legal advice, much less lead you to believe that marijuana is legal under federal law.